Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Non-Current Deferred Tax Liability (2022 - 2025)

Historic Non-Current Deferred Tax Liability for InMed Pharmaceuticals (INM) over the last 3 years, with Q2 2025 value amounting to $20000.0.

  • InMed Pharmaceuticals' Non-Current Deferred Tax Liability changed N/A to $20000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $20000.0, marking a year-over-year change of. This contributed to the annual value of $20000.0 for FY2025, which is N/A changed from last year.
  • Per InMed Pharmaceuticals' latest filing, its Non-Current Deferred Tax Liability stood at $20000.0 for Q2 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Non-Current Deferred Tax Liability peaked at $211266.0 during Q2 2023, and registered a low of $20000.0 during Q2 2025.
  • Over the past 3 years, InMed Pharmaceuticals' median Non-Current Deferred Tax Liability value was $71806.0 (recorded in 2022), while the average stood at $101024.0.
  • Data for InMed Pharmaceuticals' Non-Current Deferred Tax Liability shows a peak YoY increase of 19421.78% (in 2023) and a maximum YoY decrease of 19421.78% (in 2023) over the last 5 years.
  • Over the past 3 years, InMed Pharmaceuticals' Non-Current Deferred Tax Liability (Quarter) stood at $71806.0 in 2022, then soared by 194.22% to $211266.0 in 2023, then tumbled by 90.53% to $20000.0 in 2025.
  • Its Non-Current Deferred Tax Liability stands at $20000.0 for Q2 2025, versus $211266.0 for Q2 2023 and $71806.0 for Q2 2022.